Mechanism of action of levonorgestrel contraceptive implants

Gynecological Endocrinology

Volumn 15, Issue SUPPL. 2, 2001, Pages 14-20

  Brache, V ^a   Alvarez, F ^a   Faundes, A ^a  

^a PROFAMILIA   (Dominican Republic)

Author keywords

Cervical mucus; Contraception; Levonorgestrel implant; Norplant; Ovulation inhibition; Ovulatory dysfunction; Two rod system

Indexed keywords

EID: 21544468854     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.15.s2.14.20     Document Type: Article

References (14)

1. Friberg J, Gemzell C. Daily postcoital tests in the conception cycle during treatment of anovulatory women with human gonadotropins. Int J Fertil 1972;17:178-82
2. Katz DF, Overstreet JW, Hanson FW. A new quantitative test of sperm penetration into cervical mucus. Fertil Steril 1980;33:179-86
3. Brache V, Faúndes A, Johansson E, Alvarez F. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. Contraception 1985;31:261-73
4. Croxatto HB, Diaz S, Salvatierra AM, Morales P, Ebensperger C, Brandeis A. Treatment with Norplant® subdermal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 1987;36:193-201
5. Dunson TR, Blumenthal PD, Alvarez F, et al. Timing of onset of contraceptive effectiveness in Norplant implant users. 1. Changes in cervical mucus. Fertil Steril 1998;69:258-66
6. Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants. Acta Endocrinol 1982;101:307-11
7. Brache V, Alvarez-Sanchez F, Faúndes A, Tejada AS, Cochon L. Ovarian endocrine function through five years of continuous treatment with Norplant® subdermal contraceptive implants. Contraception 1990;41:169-77
8. Croxatto HB, Diaz S, Pavez M, Brandeis A. Estradiol plasma levels during long-term treatment with Norplant subdermal implants. Contraception 1988;38:465-75
9. Faúndes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Fertil Steril 1991; 56:27-31
10. Zelinski-Wooten MB, Lazendorf SE, Wolf DP, Alain-Chadrasekher Y, Stouffer RL. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function. J Clin Endocrinol Metab 1991;73:577-83
11. Olsson S-E, Bakos O, Lindgren P-G, Odlind V, Wide L. Ovarian function during use of subdermal implants releasing low doses of levonorgestrel. Br J Fam Plann 1990;16:88-93
12. Shoupe D, Horenstein J, Mishell, DR, Jr., Lacarra M, Medearis A. Characteristics of ovarian follicular development in Norplant users. Fertil Steril 1991; 55:766-70
13. Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa E-A, Ahmed A-G. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Fertil Steril 1993;59: 998-1002
14. Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implant users with regular menses. Contraception 1996;54:275-9